In section Market Quotes

Health-Care Stocks Fall Less Than the Broad Market as Deals Emerge

Health-care companies declined amid a broad market drop, but their losses were smaller. Deal activity included Johnson & Johnson’s agreement to acquire Ollin Biosciences and Eli Lilly’s planned purchase of Calytrix Bio.

Health-Care Stocks Fall Less Than the Broad Market as Deals Emerge

Johnson & Johnson agreed to pay an initial $2.2 billion for biotech firm Ollin Biosciences. It also struck a deal with investment firm Blackstone to fund development of Ollin’s lead eye-care product candidate.

Eli Lilly agreed to pay up to $1.5 billion to acquire Calytrix Bio, a closely held biotechnology company backed by JPMorgan. Calytrix is developing treatments for a group of rare blood cancers.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!